Eli Lilly
North America, Indiana, United States, Indianapolis
Description
Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.
Investor Profile
Eli Lilly has made 99 investments, with 22 in the past 12 months and 22% as lead.
Stage Focus
- Series A (35%)
- Series B (24%)
- Series C (9%)
- Series Unknown (9%)
- Seed (8%)
- Post Ipo Equity (5%)
- Corporate Round (4%)
- Series D (3%)
- Pre Seed (1%)
- Undisclosed (1%)
Country Focus
- United States (73%)
- United Kingdom (12%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (4%)
- The Netherlands (2%)
- Belgium (2%)
- France (2%)
- China (1%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Japan (1%)
- Switzerland (1%)
- Singapore (1%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Biopharma
- Life Science
- Genetics
- Oncology
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
